Sg3 Management, LLC Ionis Pharmaceuticals Inc Transaction History

Sg3 Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $187,646 - $232,611	6,280 Added 73.88%	14,780 $547,000
Q4 2021 Feb 15, 2022	SELL	$25.61 - $35.1 $256,100 - $351,000	-10,000 Reduced 54.05%	8,500 $259,000
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $1.8 Million - $2.18 Million	-53,800 Reduced 74.41%	18,500 $620,000
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $1.81 Million - $2.47 Million	52,300 Added 261.5%	72,300 $2.88 Million
Q1 2021 May 17, 2021	BUY	$42.51 - $63.78 $318,825 - $478,350	7,500 Added 60.0%	20,000 $899,000
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $203,850 - $271,215	-4,500 Reduced 26.47%	12,500 $707,000
Q3 2020 Nov 13, 2020	BUY	$47.45 - $62.95 $806,650 - $1.07 Million	17,000 New	17,000 $807,000
Q4 2017 Feb 13, 2018	SELL	$50.3 - $64.39 $930,550 - $1.19 Million	-18,500 Closed	0 $0
Q3 2017 Jan 25, 2018	BUY	$45.56 - $59.57 $842,860 - $1.1 Million	18,500	18,500 $938,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.16B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.